Drug Shortage Report for GAMMAGARD S/D
Report ID | 207306 |
Drug Identification Number | 02231470 |
Brand name | GAMMAGARD S/D |
Common or Proper name | Immunoglobulin Intravenous (Human) |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IMMUNOGLOBULIN |
Strength(s) | 5G |
Dosage form(s) | KIT SOLUTION POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100 mL Vial |
ATC code | J06BA |
ATC description | IMMUNOGLOBULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-12-15 |
Actual start date | |
Estimated end date | 2024-04-30 |
Actual end date | 2024-01-29 |
Shortage status | Resolved |
Updated date | 2024-01-31 |
Company comments | Shortage related to the disruption in supply of co-packaged sterile Water for Injection and not related to the immunoglobulin drug product. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2024-01-31 | English | Compare |
v15 | 2023-12-16 | English | Compare |
v14 | 2023-10-18 | French | Compare |
v13 | 2023-10-18 | English | Compare |
v12 | 2023-10-18 | French | Compare |
v11 | 2023-10-18 | English | Compare |
v10 | 2023-10-18 | French | Compare |
v9 | 2023-10-18 | English | Compare |
v8 | 2023-10-18 | French | Compare |
v7 | 2023-10-18 | English | Compare |
v6 | 2023-10-18 | French | Compare |
v5 | 2023-10-18 | English | Compare |
v4 | 2023-10-18 | French | Compare |
v3 | 2023-10-18 | English | Compare |
v2 | 2023-10-18 | French | Compare |
v1 | 2023-10-18 | English | Compare |
Showing 1 to 16 of 16